Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-03-14

Clinical Trial Update: 5% Lidocaine-medicated Plaster for the Treatment of Trigeminal Neuralgia [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update on a 5% lidocaine medicated plaster for treating trigeminal neuralgia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • lidocaine medicated plaster 5% (lidocaine)

Snippet

Sponsor: Beijing Tiantan Hospital | Conditions: Trigeminal Neuralgia | Phase 4 | Status: COMPLETED